Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. In a move that could dramatically reshape the landscape for rare ...

Exagen Inc. has received conditional approval from the New York State Department of Health for its new biomarker assays for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), which are ...

Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global marketplace, the drug approval standard employed by FDA remains a ...